Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial.
- Author:
Zhiyi ZHOU
;
Ling XU
;
Hegen LI
;
Jianhui TIAN
;
Lijing JIAO
;
Shengfu YOU
;
Zhifen HAN
;
Yi JIANG
;
Huiru GUO
;
Hui LIU
- Publication Type:Journal Article
- From:
Journal of Integrative Medicine
2014;12(3):175-81
- CountryChina
- Language:English
-
Abstract:
Traditional Chinese medicine (TCM) is considered an important complementary therapy with beneficial effects for cancer patients. Elderly patients with non-small-cell lung cancer (NSCLC) are a complex patient group with increasing co-morbidity and shrinking physiological reserve, and may derive substantial benefit from the supportive aspects of TCM. Researchers from Shanghai Longhua Hospital found that qi and yin deficiency is a common syndrome in patients with stage III or IV lung cancer. This project was designed to study the combination of single-agent chemotherapy with TCM methods of benefiting qi and yin in elderly patients with advanced NSCLC.
